HKEX documents show that this Suzhou biotech company has officially launched its IPO process, with Dongxing Securities as the exclusive sponsor — the financing window for the innovative drug industry chain remains active.

View Original
MarsBitNews
Zhixiang Biology submits listing application to the Hong Kong Stock Exchange
Mars Finance News: According to Hong Kong Stock Exchange documents, on June 1st, Zhixiang Biology (Suzhou) Co., Ltd. submitted an application for listing to the Hong Kong Stock Exchange, with Dongxing Securities (Hong Kong) serving as the exclusive sponsor.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned